Related Experiment Video
Updated: Jun 11, 2025

14:27
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
15.6K
Clinical outcome-guided deep temporal clustering for disease progression subtyping
Dulin Wang1, Xiaotian Ma1, Paul E Schulz2
1McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Journal of Biomedical Informatics
|October 2, 2024
Summary
This study introduces a novel framework for clustering complex diseases, identifying distinct patient subtypes based on disease progression and clinical outcomes. The approach enhances personalized treatment strategies by revealing subgroup variations.
Area of Science:
- Biomedical Informatics
- Computational Biology
- Data Science
Background:
- Complex diseases show varied progression, requiring methods to identify subtypes for personalized medicine.
- Current approaches often lack clustering-specific representations or fail to integrate clinical outcomes, limiting utility.
Purpose of the Study:
- To develop a unified framework for subtyping longitudinal progressive diseases.
- To improve patient representation for clustering by integrating disease progression data and clinical outcomes.
Main Methods:
- Proposed Outcome-Guided Deep Temporal Clustering (OG-DTC) framework.
- Utilized a GRU-based seq2seq architecture for temporal dynamics, integrating k-means clustering and outcome regression.
- Clustered representations using Gaussian mixture models and validated through reproducibility, stability, and significance tests.
Main Results:
- Applied the framework to Alzheimer's Disease (AD) clinical trials, identifying three distinct subtypes.
- Subtypes showed unique progression patterns and differentiated clinical declines.
- Ablation studies confirmed the contribution of each model component, with joint optimization improving representations.
Conclusions:
- The temporal clustering framework provides robust subtyping for longitudinal diseases.
- The method has potential to capture subtype variability in clinical outcomes for personalized treatments.

